Are we Loading Our Patients With Sodium During Hemodialysis Treatments?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01454193
Recruitment Status : Completed
First Posted : October 18, 2011
Last Update Posted : October 19, 2011
Information provided by (Responsible Party):
Renal Research Institute

Brief Summary:
The objectives of the data search is to find out if there is correlation between pre, post serum sodium concentration, dialysate sodium concentration, interdialytic weight gain and associated changes in pre and post systolic and diastolic blood pressure, mean arterial pressure, number of blood pressure medications and adherence to 3 times per week dialysis, mortality.

Condition or disease
Renal Failure

Study Type : Observational
Actual Enrollment : 10000 participants
Observational Model: Cohort
Time Perspective: Retrospective
Study Start Date : January 2001
Actual Primary Completion Date : October 2011
Actual Study Completion Date : October 2011

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 88 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Hemodialysis patients at Renal Research Institute and Fresenius clinics

Inclusion Criteria:

  • Hemodialysis patient

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01454193

United States, New York
Renal Research Institute
New York, New York, United States, 10128
Sponsors and Collaborators
Renal Research Institute
Principal Investigator: Peter Kotanko, MD Renal Research Institute

Responsible Party: Renal Research Institute Identifier: NCT01454193     History of Changes
Other Study ID Numbers: 078-08
First Posted: October 18, 2011    Key Record Dates
Last Update Posted: October 19, 2011
Last Verified: October 2011

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Diseases
Urologic Diseases